S Mitsuhashi
About
In The Last Decade
S Mitsuhashi
184 papers receiving 5.4k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Molecular Medicine 3.8k
- Pharmacology 2.4k
- Molecular Biology 1.9k
- Epidemiology 918
- Endocrinology 906
Countries citing papers authored by S Mitsuhashi
This map shows the geographic impact of S Mitsuhashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Mitsuhashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Mitsuhashi more than expected).
Fields of papers citing papers by S Mitsuhashi
This network shows the impact of papers produced by S Mitsuhashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Mitsuhashi. The network helps show where S Mitsuhashi may publish in the future.
Co-authorship network of co-authors of S Mitsuhashi
This figure shows the co-authorship network connecting the top 25 collaborators of S Mitsuhashi. A scholar is included among the top collaborators of S Mitsuhashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Mitsuhashi. S Mitsuhashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | Antibacterial activity of panipenem, a new carbapenem antibiotic | 9 |
| 4 | 10 | |
| 5 | 28 | |
| 6 | 6 | |
| 7 | 53 | |
| 8 | The structure and mechanical properties of sheets prepared from bacterial cellulose breakdown → | 457 |
| 9 | 18 | |
| 10 | 3 | |
| 11 | 10 | |
| 12 | [Studies on the drug resistance of enteric bacteria. 14. On artificial elimination of transmissible drug-resistance by means of acriflavine]. | 3 |
| 13 | 1 | |
| 14 | Studies on the Drug-Resistance of Enteric Bacteria. 7. Type of the Transmissible Drug-Resistance Factor. | 11 |
| 15 | On the drug-resistance of enteric bacteria. 4. Drug-resistance of Shigella prevalent in Japan. | 17 |
| 16 | Drug-Resistance of Enteric Bacteria. 13. Interference of R Factors in the R+ Bacterial Cell when infected with another R Factor. | 12 |
| 17 | Drug-Resistance of Staphylococci. 1. Transduction of Drug-Resistance in Staphylococcus aureus. | 2 |
| 18 | Studies on the Drug-Resistance of Enteric Bacteria. 8. Isolation of Kanamycin-Resistant Citrobacter and Escherichia coli. | 1 |
| 19 | Drug-Resistance of Enteric Bacteria. 14. Interference between R(CM) and R(TC) Factors in the R+ (CM) or R+ (TC) Bacteria when infected with either one of both Factors. | 3 |
| 20 | On the production of the toxin by C.Diphtheriae | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.